Cargando…
Excess All-Cause Mortality During the COVID-19 Outbreak in Japan
Autores principales: | Yorifuji, Takashi, Matsumoto, Naomi, Takao, Soshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Epidemiological Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738637/ https://www.ncbi.nlm.nih.gov/pubmed/33132284 http://dx.doi.org/10.2188/jea.JE20200492 |
Ejemplares similares
-
Effect of mRNA Vaccines in Preventing COVID-19 Severe Pneumonia Among COVID-19 Patients in Japan
por: Matsuo, Rumi, et al.
Publicado: (2022) -
Antibody Titers After a Third and Fourth SARS-CoV-2 Vaccine Dose in Bizen City, Japan
por: Kadowaki, Tomoka, et al.
Publicado: (2023) -
Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan
por: Matsumoto, Naomi, et al.
Publicado: (2023) -
Effectiveness of the Original COVID-19 Vaccine against COVID-19 Exacerbations during the Omicron Wave: A Population-based Study in Okayama, Japan
por: Matsumoto, Naomi, et al.
Publicado: (2023) -
Letter to the editor: COVID-19 and all-cause excess mortality in Iran in spring 2020
por: Tadbiri, Hooman, et al.
Publicado: (2020)